Personalized, Transdiagnostic Approach to Preventative Mental Health

Last updated: May 10, 2019
Sponsor: Introspect Health
Overall Status: Active - Recruiting

Phase

N/A

Condition

Schizophrenia And Schizoaffective Disorders (Pediatric)

Schizotypal Personality Disorder (Spd)

Treatment

N/A

Clinical Study ID

NCT03946319
IH-001
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This study is investigating the self-report adherence and assessment completion rates when presented with a transdiagnostic, partial assessment multiple times a day when compared with a monotopic, complete assessment once a day. Specifically, the investigators are testing the hypothesis that the personalization of diagnostic assessment topics and timing will lead to improved self-report regiment adherence rates, assessment completion rates, and total assessments completed during the study period. The study does not test the efficacy of the personalized assessments as a diagnostic instrument, there is no clinical decision support provided to clinicians during this study, and there is no treatment provided during this study.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age 18 or older

  • English fluency

  • US citizen

  • California resident

  • Eligible to receive mental healthcare in the state of California

  • Primary user of a smartphone device

  • Daily access to Internet and email

  • Meets a minimum level of 2.51 or higher on a self-rated technology use scale based onthe average score of three Likert-style questions

  • Willing to answer questions about themselves pertaining to physical and mentalwellness throughout the Research Period

Exclusion

Exclusion Criteria:

  • Undergoing care for condition requiring emergent treatment or hospitalization,including but not limited to: current or recent (within 3 months) acute manic or majordepressive episode, clear and current suicidal risk, current or recent (within 3months) history of substance abuse or drug dependence

  • Undergoing active treatment for a condition wherein the additional burden ofperforming daily assessments may interfere with their pre-existing treatment regiment,cause undue anxiety, or risk inflammation of pre-existing issues

  • Undergoing active treatment using a treatment modality that may adversely interactwith research study participation such as psychopharmaceuticals affecting memory andcognition, therapeutic digital detox, or similar treatments

  • Has ever participated in a Research Study testing the efficacy of transdiagnosticassessments, transdiagnostic interventions, or Internet-based CBT

  • Additionally, patients on psychotropic medications are only eligible to be includedwhile they maintain a stable dosage of their medication; if their medication dosageneeds to change for any reason during the course of the Research Study, they would berequired to withdraw from the study.

Study Design

Total Participants: 50
Study Start date:
May 01, 2019
Estimated Completion Date:
August 31, 2019

Study Description

Broadly, the goal of Introspect Health is to shift clinical practice from reactively treating psychiatric disorders and mental health issues once manifested to a preventative care model for integrative mental health in a way that is cost-effective and scalable. One of the principal areas of struggle in preventative mental health is self-report adherence and the ability for primary care physicians and non-psychiatrists to perform mental health surveillance with their patients. This study specifically examines the relationship between individuals and a novel self-report assessment tool. To do this, the investigators are performing a randomized controlled trial with two classes of users (the general public and patients undergoing treatment for mental health issues) for a six week trial comparing the novel self-report assessment tool to the standard of care assessment tools available to clinicians. Participants will be randomized to one of the two daily assessment regiments within the internet-delivered assessment tool: one that is representative of standard of care monitoring and one that is personalized both in terms of content and timing based on the participant's intake as well as ongoing participation. Neither the participants nor researcher will be aware of which arm the individual is randomized. After using the software for six weeks, the data will be analyzed specifically targeting self-adherence and assessment completion metrics to evaluate the potential benefits of a transdiagnostic assessment system over the standard-of-care monotopic assessment system. Assessment scoring is handled by an automated scoring engine, using the rules set forth by the standards in the assessment protocols. The study does not test the efficacy of the personalized assessments as a diagnostic instrument, there is no clinical decision support provided to clinicians during this study, and there is no treatment provided during this study.

Connect with a study center

  • California Institute of Integral Studies

    San Francisco, California 94103
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.